This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing Urogen's UGN-102 and its potential in LG-IR-NMIBC following the ATLAS and ENVISION top line
Ticker(s): URGNWho's the expert?
Institution: One Urology
- Urologist at One Urology in California.
- Currently manages 125-200 patients with bladder cancer.
- Clinical focus on urologic cancer, stone disease, incontinence, erectile dysfunction, men’s health, and infertility.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
